A detailed history of Accent Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Accent Capital Management, LLC holds 1,500 shares of ABBV stock, worth $268,800. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,500 -0.0%
Holding current value
$268,800
Previous $257 Million 15.14%
% of portfolio
0.17%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $319,640 - $364,200
-2,000 Reduced 57.14%
1,500 $273 Million
Q4 2023

Mar 19, 2024

BUY
$137.6 - $154.97 $481,600 - $542,395
3,500 New
3,500 $542 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.